Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ranjeet Gutte"'
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 1, Pp 47-52 (2019)
The purpose of this study was to measure the electrocardiographic (ECG) effects of WCK 2349 (the L‐alanine ester prodrug of levonadifloxacin) at a supratherapeutic oral dose of 2,600 mg. A total of 48 healthy volunteers were randomized to treatment
Externí odkaz:
https://doaj.org/article/65032b2fa36a44a1ae8231c6c846975d
Autor:
Behram Pardiwalla, Preeti Narayan, Nimitt Nagda, A. Bopardikar, Honey Savla, Manishkumar Shah, Kedar Toraskar, Vijay R. Sharma, Ajaykumar Yadav, Ranjeet Gutte, Dhananjay Kumbhar, Ashima Bhatia, Dhaval Gohel
Publikováno v:
Journal of Current Medical Research and Opinion. 4:940-949
Objective: With few treatment options available to manage coronavirus disease 2019 (COVID-19), health systems devised strategies to manage covid-19 using repurposed drugs and revisiting older strategies, such as convalescent plasma. This study was pl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::906ed687adc1417a5c869aade643fc9c
https://doi.org/10.15520/jcmro.v4i05.419
https://doi.org/10.15520/jcmro.v4i05.419
Autor:
B. S. Chandrashekar, Kalpana Sarangi, Mushtaque A Mastim, Ashima Bhatia, Manishkumar Shah, Vijay Sharma, Mugdha Gupta, Ranjeet Gutte, Anuka Sharma, Ulka Sakhalkar
Publikováno v:
Cureus. 14(5)
Background Growth factors from platelets have been emerging as a revolutionary treatment with the ability to induce cell growth in the skin, which results in retarding and reversing the aging process. Platelet-rich plasma (PRP) allows for greater rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7513fcd442bdcd6356d0222bdd8e242b
https://pubmed.ncbi.nlm.nih.gov/35747053
https://pubmed.ncbi.nlm.nih.gov/35747053
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 12, Iss 1, Pp 47-52 (2019)
Clinical and Translational Science, Vol 12, Iss 1, Pp 47-52 (2019)
The purpose of this study was to measure the electrocardiographic (ECG) effects of WCK 2349 (the L‐alanine ester prodrug of levonadifloxacin) at a supratherapeutic oral dose of 2,600 mg. A total of 48 healthy volunteers were randomized to treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a913424bc1ac98e836293f3060814fb
http://europepmc.org/articles/PMC6342240
http://europepmc.org/articles/PMC6342240